日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing

TOP2A 表达可预测骨髓瘤对卡非佐米的反应性,并为增强蛋白酶体抑制剂细胞杀伤力提供新的组合策略

Antonia Reale, Tiffany Khong, Sridurga Mithraprabhu, Ioanna Savvidou, Jay Hocking, Krystal Bergin, Malarmathy Ramachandran, Maoshan Chen, Francesco Dammacco, Roberto Ria, Francesco Silvestris, Angelo Vacca, John Reynolds, Andrew Spencer

DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients

DNA 修复基因突变在多发性骨髓瘤患者的循环肿瘤 DNA 中非常普遍

Sridurga Mithraprabhu, Jay Hocking, Malarmathy Ramachandran, Kawa Choi, Daniela Klarica, Tiffany Khong, John Reynolds, Andrew Spencer